Metformin and Mifepristone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metformin (metformin hydrochloride) and Mifepristone (mifepristone). Common drug interactions include formication among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Metformin and Mifepristone. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.

What is Mifepristone?

Mifepristone has active ingredients of mifepristone. eHealthMe is studying from 3,112 Mifepristone users. Check the latest studies of Mifepristone.



On Jul, 11, 2026

42 people who take Metformin and Mifepristone together, and have interactions are studied.

Metformin and Mifepristone drug interactions.

What are the common drug interactions of Metformin and Mifepristone, by gender? *:

female:

  1. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
  2. Hallucination (an experience involving the perception of something not present)
  3. Hypersomnia (excessive daytime sleepiness (eds))
  4. Rash
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Vaginal haemorrhage (vaginal bleeding)
  7. Anaemia (lack of blood)
  8. Anxiety
  9. Back pain
  10. Chest pain

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Blood glucose increased
  3. Blood potassium decreased
  4. Constipation
  5. Pain in extremity
  6. Blood sodium decreased
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Feeling jittery
  9. Peripheral swelling
  10. Weight increased

What are the common drug interactions of Metformin and Mifepristone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Haemorrhage (bleeding)
  2. Palpable purpura (purple or brownish-red spots on the skin or mucous)
  3. Vasculitis (inflammation of a blood vessel or blood vessels)

30-39:

  1. Blood glucose decreased
  2. Drug resistance (reduction in effectiveness of a drug)
  3. Blood glucose increased
  4. Constipation
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Hyperthyroidism (over activity of the thyroid gland)
  8. Nausea (feeling of having an urge to vomit)
  9. Presyncope
  10. Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

  1. Dizziness
  2. Insomnia (sleeplessness)
  3. Nausea (feeling of having an urge to vomit)
  4. Anaemia (lack of blood)
  5. Haematuria (presence of blood in urine)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Arthralgia (joint pain)
  8. Blood glucose increased
  9. Blood pressure increased
  10. Blood thyroid stimulating hormone decreased

50-59:

  1. Dizziness
  2. Headache (pain in head)
  3. Constipation
  4. Arthralgia (joint pain)
  5. Vomiting
  6. Dyspnoea (difficult or laboured respiration)
  7. Feeling jittery
  8. Insomnia (sleeplessness)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Peripheral swelling

60+:

  1. Blood pressure increased
  2. Dizziness
  3. Pain in extremity
  4. Swelling
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Oedema peripheral (superficial swelling)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Dry eye (lack of adequate tears)
  10. Eye irritation

What are the existing conditions these people have? *

  1. Cushing's Syndrome (obesity, a rounded face, increased fat): 36 people, 85.71%
  2. Type 2 Diabetes: 6 people, 14.29%
  3. High Blood Pressure: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and Mifepristone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metformin and Mifepristone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mifepristone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mifepristone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride and mifepristone (the active ingredients of Metformin and Mifepristone, respectively), and Metformin and Mifepristone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: